跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MARCAIN 0.125% WITH FENTANYL 100 mcg/20mL bupivacaine hydrochloride 1.25mg/mL and fentanyl 5 mcg/mL (citrate) 20mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
MARCAIN 0.125% WITH FENTANYL 100 mcg/20mL bupivacaine hydrochloride 1.25mg/mL and fentanyl 5 mcg/mL (citrate) 20mL injection ampoule
Approved
STANDARD
MARCAIN 0.125% WITH FENTANYL 100 mcg/20mL bupivacaine hydrochloride 1.25mg/mL and fentanyl 5 mcg/mL (citrate) 20mL injection ampoule
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f87dfe0e06ba2f73
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f87dfe0e06ba2f73
Product Name
MARCAIN 0.125% WITH FENTANYL 100 mcg/20mL bupivacaine hydrochloride 1.25mg/mL and fentanyl 5 mcg/mL (citrate) 20mL injection ampoule
Artg Id
123384
Artg Name
MARCAIN 0.125% WITH FENTANYL 100 mcg/20mL bupivacaine hydrochloride 1.25mg/mL and fentanyl 5 mcg/mL (citrate) 20mL injection ampoule
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2006-03-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f87dfe0e06ba2f73
Type
Standard
Back to TGA Approvals